Amplitude Surgical SAS (AMPLI) - Total Liabilities

Latest as of December 2024: €184.97 Million EUR ≈ $216.25 Million USD

Based on the latest financial reports, Amplitude Surgical SAS (AMPLI) has total liabilities worth €184.97 Million EUR (≈ $216.25 Million USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Amplitude Surgical SAS to track the company's year-over-year net asset growth rate.

Amplitude Surgical SAS - Total Liabilities Trend (2011–2024)

This chart illustrates how Amplitude Surgical SAS's total liabilities have evolved over time, based on quarterly financial data.

Amplitude Surgical SAS Competitors by Total Liabilities

The table below lists competitors of Amplitude Surgical SAS ranked by their total liabilities.

Company Country Total Liabilities
Socar Inc.
KO:403550
Korea ₩458.63 Billion
Innovative Solutions and Support
NASDAQ:ISSC
USA $41.19 Million
Palladyne AI Corp
NASDAQ:PDYN
USA $21.04 Million
Y.U.D. Yangtze River Investment Industry Co Ltd
SHG:600119
China CN¥275.07 Million
Colonial Coal International Corp
V:CAD
Canada CA$106.36K
Galaxy Far East
TWO:6227
Taiwan NT$5.79 Billion
Editas Medicine Inc
NASDAQ:EDIT
USA $144.93 Million
Eledon Pharmaceuticals Inc
NASDAQ:ELDN
USA $100.82 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Amplitude Surgical SAS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Amplitude Surgical SAS.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.91 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.04 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.95 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.66 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Amplitude Surgical SAS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Amplitude Surgical SAS (2011–2024)

The table below shows the annual total liabilities of Amplitude Surgical SAS from 2011 to 2024.

Year Total Liabilities Change
2024-06-30 €183.43 Million
≈ $214.45 Million
+7.77%
2023-06-30 €170.20 Million
≈ $198.99 Million
-17.73%
2022-06-30 €206.89 Million
≈ $241.88 Million
-2.50%
2021-06-30 €212.21 Million
≈ $248.09 Million
+3.87%
2020-06-30 €204.29 Million
≈ $238.84 Million
+5.07%
2019-06-30 €194.43 Million
≈ $227.31 Million
+0.47%
2018-06-30 €193.52 Million
≈ $226.25 Million
+15.31%
2017-06-30 €167.82 Million
≈ $196.21 Million
+20.61%
2016-06-30 €139.15 Million
≈ $162.68 Million
+8.44%
2015-06-30 €128.31 Million
≈ $150.01 Million
-15.93%
2014-06-30 €152.62 Million
≈ $178.43 Million
+26.27%
2013-06-30 €120.87 Million
≈ $141.31 Million
+12.08%
2012-06-30 €107.84 Million
≈ $126.08 Million
+8.33%
2011-06-30 €99.55 Million
≈ $116.38 Million
--

About Amplitude Surgical SAS

PA:AMPLI France Medical Instruments & Supplies
Market Cap
$350.55 Million
€299.85 Million EUR
Market Cap Rank
#15041 Global
#219 in France
Share Price
€6.25
Change (1 day)
+0.00%
52-Week Range
€6.05 - €6.30
All Time High
€6.30
About

Amplitude Surgical SA designs, develops, and markets products for orthopedic surgery in France and internationally. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgery system; the i.M.A.G.E., a single-u… Read more